학술논문
In higher-risk, statin-intolerant adults with diabetes, bempedoic acid reduced MACE at a median 3 y.
Document Type
Article
Author
Source
Subject
*ADULTS
*DIABETES
*MAJOR adverse cardiovascular events
*BIBLIOGRAPHICAL citations
*PEOPLE with diabetes
*
*
*
*
Language
ISSN
0003-4819
Abstract
Source Citation: Ray KK, Nicholls SJ, Li N, et al; CLEAR OUTCOMES Committees and Investigators. Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial. Lancet Diabetes Endocrinol. 2024;12:19-28. 38061370 Clinical Impact Ratings: GIM/FP/GP: Cardiology: Endocrinology: Public Health: [ABSTRACT FROM AUTHOR]